Induction of mucosal immunity through systemic immunization: Phantom or reality?
F Su, GB Patel, S Hu, W Chen - Human vaccines & …, 2016 - Taylor & Francis
Generation of protective immunity at mucosal surfaces can greatly assist the host defense
against pathogens which either cause disease at the mucosal epithelial barriers or enter the …
against pathogens which either cause disease at the mucosal epithelial barriers or enter the …
Recent advances in developing vaccines against Toxoplasma gondii: an update
NZ Zhang, M Wang, Y Xu, E Petersen… - Expert Review of …, 2015 - Taylor & Francis
Toxoplasma gondii, a significant public health risk, is able to infect almost all warm-blooded
animals including humans, and it results in economic losses in production animals. In the …
animals including humans, and it results in economic losses in production animals. In the …
Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c …
Many recent studies have been conducted to evaluate protective immunity mediated by DNA
vaccines against toxoplasmosis. Cocktail DNA vaccines showed better immune responses …
vaccines against toxoplasmosis. Cocktail DNA vaccines showed better immune responses …
Vaccination with Toxoplasma lysate antigen or its encapsulated niosomes form immunomodulates adjuvant-induced arthritis through JAK3 downregulation
Background Inflammatory autoimmune arthritis like that present in rheumatoid arthritis (RA)
is treated by medications with many side effects. This study was a trial to benefit from …
is treated by medications with many side effects. This study was a trial to benefit from …
Nano-encapsulated antioxidant: retinoic acid as a natural mucosal adjuvant for intranasal immunization against chronic experimental toxoplasmosis
The tight relationship between immunity and retinoid levels provides evidence on the critical
role of retinoic acid (RA) in regulating immune activity, especially the mucosal one. Mucosal …
role of retinoic acid (RA) in regulating immune activity, especially the mucosal one. Mucosal …
Vaccination challenges and strategies against long-lived Toxoplasma gondii
Since the discovery of Toxoplasma gondii in 1908, it is estimated that one-third of the global
population has been exposed to this ubiquitous intracellular protozoan. The complex life …
population has been exposed to this ubiquitous intracellular protozoan. The complex life …
Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice
Toxoplasma gondii, the etiological agent of toxoplasmosis, can cause severe or lethal
damages in both animals and man. So, tends to develop a more effective vaccine to prevent …
damages in both animals and man. So, tends to develop a more effective vaccine to prevent …
Review on the identification and role of Toxoplasma gondii antigenic epitopes
Y Wang, G Wang, J Cai, H Yin - Parasitology research, 2016 - Springer
Toxoplasma gondii is an obligate intracellular protozoan parasite with a broad range of
hosts, and it causes severe toxoplasmasis in both humans and animals. It is well known that …
hosts, and it causes severe toxoplasmasis in both humans and animals. It is well known that …
Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii
Toxoplasma gondii can cause severe and even fatal disease in human beings and animals.
Effective vaccines may contribute to control toxoplasmosis. GRA 14, a novel secreted dense …
Effective vaccines may contribute to control toxoplasmosis. GRA 14, a novel secreted dense …
Protective effect of a DNA vaccine cocktail encoding ROP13 and GRA14 with Alum nano-adjuvant against Toxoplasma gondii infection in mice
Toxoplasma gondii is an obligate intracellular protozoan parasite that can cause serious
public health problems. The development of a safe and effective vaccine against T. gondii is …
public health problems. The development of a safe and effective vaccine against T. gondii is …